FDA Approves New Drug For the Treatment of Alzheimer’s Disease

In early July, the Food and Drug Administration (FDA) approved the drug Lecanemab (Leqembi) to treat Alzheimer’s disease in adult patients. Read the full FDA announcement here: https://tinyurl.com/59huh8rp

JWM’s neurologists diagnose and treat Alzheimer’s disease and other types of dementia. We are also participating in multiple clinical trials for these diseases.

For more information on our clinical trials, contact our Research Department at 317-537-6061.